Several experts advise to lower the dose of sulfonylurea and short-acting and low-acting insulin analogues prior to or during titration of GLP-1RA therapy, to reduce the risk of (severe) hypoglycemia ( Gastrointestinal (GI) Adverse Effects In the phase 3 trials, both oral and subcutaneous semaglutide were associated with gastrointestinal disturbances, such as nausea, vomiting and diarrhea, well-known effects from this drug class
It's used by 372,000 GLP-1 members with a 4.8-star rating across more than 16,000 App Store reviews.
P (03) 9417 1555 [email protected] www.winnettspecialistgroup.com.au Queens Terrace, 382 Victoria Parade, East Melbourne 3002 Sources: 2* EASO 2024 Is coming off semaglutide slowly the key to preventing weight regain
Predictable fat reduction with medical supervision
Until then, conservative use and clinician consultation for at-risk individuals are sensible steps